Mariner
NAGE

Mariner’s Niagen Bioscience NAGE Stock Holding History

Mariner’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.9K Sell
23,773
-25,225
-51% -$102K ﹤0.01% 3366
2026
Q1 		$216K Buy
48,998
+30,406
+164% +$164K ﹤0.01% 3126
2025
Q4 		$118K Sell
18,592
-658
-3% -$4.58K ﹤0.01% 3299
2025
Q3 		$180K Buy
19,250
+250
+1% +$2.52K ﹤0.01% 3211
2025
Q2 		$274K Buy
+19,000
New +$188K ﹤0.01% 2792

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mariner's NAGE Position: Q2 2026 in Review

Mariner reduced its Niagen Bioscience (NAGE) stake by 51% in Q2 2026, selling an estimated $102K and leaving 23,773 shares worth $75.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Mariner first reported a position in NAGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $274K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Mariner held 23,773 shares of Niagen Bioscience worth $75.9K as of Q2 2026.
  • Mariner sold 25,225 Niagen Bioscience shares in Q2 2026, an estimated $102K.
  • Niagen Bioscience made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3366 holding.
  • Mariner first reported a position in Niagen Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Mariner's Niagen Bioscience position peaked at $274K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.